Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoFactor vs Leucovorin in Metastatic Colorectal Cancer
NCT00337389Phase 3Unknown
- Sponsor
- Mast Therapeutics, Inc.
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of folitixorin in colorectal cancer (metastatic) (mCRC), sponsored by Mast Therapeutics, Inc.. Status: unknown.
02
Drugs
folitixorin
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT00337389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337389.